May 12, 2015 08:31 PM EDT
Survival Rate Low Among Rare Bone Cancer Patients
Research shows that survival from a rare malignancy known as mesenchymal chondrosarcoma, which begins in the cartilage around bones and typically strikes young adults, still remains low at just 20 percent for patients at the 10-year mark.
